Insider Trading26 Jun 2026, 01:24 pm
Aarey Drugs Closes Trading Window for Q2 FY27 Results
AI Summary
Aarey Drugs & Pharmaceuticals Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is effective from July 1, 2026, and will continue until 48 hours after the declaration of the Unaudited Financial Results for the quarter ended June 30, 2026. The move is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. Designated persons and their immediate relatives are prohibited from trading in the company's shares during this period to prevent insider trading.
Key Highlights
- Trading window closed from July 1, 2026, for Q2 FY27 results.
- Applies to Insiders, Designated Persons, and immediate relatives.
- Aims to prevent insider trading as per SEBI regulations.
- Trading resumes 48 hours after financial results declaration.
Price Impact
More from AREYDRG